UNSPSC 85541427: Supplement left lower extremity lymphatic with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left lower extremity lymphatic with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07UG47Z

UNSPSC 85541427 Supplement left lower extremity lymphatic with autologous tissue substitute, percutaneous endoscopic approach, a Commodity code, does not align with the recent state and local contract opportunities tagged under it. The code's nominal scope describes a surgical procedure for lymphatic system augmentation; the recent solicitations, however, span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, surgical benefit carve-out administration, and emergency medical services for detained youth — none of which involve autologous tissue grafting or lymphatic reconstruction. The mismatch suggests either a classification error in the source data or incidental tagging unrelated to the code's clinical definition. State and local procurement bodies issuing under this code appear to include county health systems, municipal retirement offices, state transportation departments, county probation agencies, and county commissioners offices across multiple functions and service lines, making it difficult to characterize a coherent buying pattern under the code as currently tagged.

No recent state and local procurement activity directly related to the Commodity code's stated scope of lymphatic tissue supplementation procedures is evident in the source material. The tagged opportunities represent medical administration, staffing, benefits management, and surveillance services rather than surgical supply or tissue-substitute procurement. Practitioners should verify code assignment with issuing authorities before pursuing opportunities under this classification, as the disconnect between the code's definition and actual solicitation scope may signal either data-quality issues in the state or local procurement platform or misapplication of the UNSPSC taxonomy to opportunities not involving autologous lymphatic grafting.